About-cancer/treatment/drugs/everolimus/zh

依维莫司

该页面包含有关依维莫司的简要信息，以及一些链接的集合，这些链接指向有关该药物的使用，研究结果和正在进行的临床试验的更多信息。

美国品牌名称

Afinitor

Afinitor Disperz

Zortress

FDA批准

是

该药物的FDA标签信息可从DailyMed获得。

用于癌症

依维莫司被批准用于治疗：

• 乳腺癌. 它与依西美坦联合用于绝经后患有晚期激素受体阳性（HR +）乳腺癌且HER2阴性（HER2-）的女性，经来曲唑或阿那曲唑治疗后并未好转。

• 胰腺癌, 胃肠道癌和肺癌（某些类型）。 它用于患有无法通过手术切除，局部晚期或转移（扩散到身体其他部位）的进行性神经内分泌肿瘤的成年人。

• 肾细胞癌（一种肾癌）晚期患者，在接受舒尼替尼或索拉非尼治疗后病情并未好转的成年人中。

• 室管膜下巨细胞星形细胞瘤 在患有结节性硬化症且无法进行手术的成人和1岁或1岁以上的儿童中。

Afinitor和Afinitor Disperz品牌已批准使用依维莫司治疗癌症。 依维莫司也被批准用于治疗移植排斥反应。 此用途已获Zortress品牌认可。

依维莫司也正在治疗其他类型的癌症。

关于依维莫司的更多信息

NCI药物词典中的定义-该药物的详细科学定义和其他名称。

MedlinePlus关于Everolimus的信息-有关该药物重要信息的通俗易懂的语言摘要，可能包括以下内容：

• 关于这种药物的警告，

• what this drug is used for and how it is used,

• what you should tell your doctor before using this drug,

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Combination Therapy Shows Promise for Treating Advanced Breast Cancer

Targeted Therapies May Be Effective Against Rare Pancreatic Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Everolimus - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.